» Articles » PMID: 33664496

Circular RNA-encoded Oncogenic E-cadherin Variant Promotes Glioblastoma Tumorigenicity Through Activation of EGFR-STAT3 Signalling

Overview
Journal Nat Cell Biol
Specialty Cell Biology
Date 2021 Mar 5
PMID 33664496
Citations 181
Authors
Affiliations
Soon will be listed here.
Abstract

Activated EGFR signalling drives tumorigenicity in 50% of glioblastoma (GBM). However, EGFR-targeting therapy has proven ineffective in treating patients with GBM, indicating that there is redundant EGFR activation. Circular RNAs are covalently closed RNA transcripts that are involved in various physiological and pathological processes. Herein, we report an additional activation mechanism of EGFR signalling in GBM by an undescribed secretory E-cadherin protein variant (C-E-Cad) encoded by a circular E-cadherin (circ-E-Cad) RNA through multiple-round open reading frame translation. C-E-Cad is overexpressed in GBM and promotes glioma stem cell tumorigenicity. C-E-Cad activates EGFR independent of EGF through association with the EGFR CR2 domain using a unique 14-amino-acid carboxy terminus, thereby maintaining glioma stem cell tumorigenicity. Notably, inhibition of C-E-Cad markedly enhances the antitumour activity of therapeutic anti-EGFR strategies in GBM. Our results uncover a critical role of C-E-Cad in stimulating EGFR signalling and provide a promising approach for treating EGFR-driven GBM.

Citing Articles

Circular RNA circCLASP2 promotes nasopharyngeal carcinoma progression through binding to DHX9 to enhance PCMT1 translation.

Peng M, Zhang S, Wu P, Hou X, Wang D, Ge J Mol Cancer. 2025; 24(1):67.

PMID: 40050914 PMC: 11884054. DOI: 10.1186/s12943-025-02272-3.


Coding circular RNA in human cancer.

Lin Y, Wang Y, Li L, Zhang K Genes Dis. 2025; 12(3):101347.

PMID: 40034125 PMC: 11875173. DOI: 10.1016/j.gendis.2024.101347.


Hsa_circ_0002301 inhibits ferroptosis in gastric cancer by encoding the de novo protein HECTD1-463aa.

Wang S, Wu C, Wang J, Yuan F, Hou Y, Cao T J Transl Med. 2025; 23(1):250.

PMID: 40022084 PMC: 11871676. DOI: 10.1186/s12967-025-06226-7.


Noncoding RNA-encoded peptides in cancer: biological functions, posttranslational modifications and therapeutic potential.

Tan S, Yang W, Ren Z, Peng Q, Xu X, Jiang X J Hematol Oncol. 2025; 18(1):20.

PMID: 39972384 PMC: 11841355. DOI: 10.1186/s13045-025-01671-9.


Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications.

Hatzimanolis O, Sykes A, Cristino A Mol Psychiatry. 2025; .

PMID: 39966624 DOI: 10.1038/s41380-025-02925-1.


References
1.
Reifenberger G, Wirsching H, Knobbe-Thomsen C, Weller M . Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol. 2016; 14(7):434-452. DOI: 10.1038/nrclinonc.2016.204. View

2.
Aldape K, Brindle K, Chesler L, Chopra R, Gajjar A, Gilbert M . Challenges to curing primary brain tumours. Nat Rev Clin Oncol. 2019; 16(8):509-520. PMC: 6650350. DOI: 10.1038/s41571-019-0177-5. View

3.
Brennan C, Verhaak R, McKenna A, Campos B, Noushmehr H, Salama S . The somatic genomic landscape of glioblastoma. Cell. 2013; 155(2):462-77. PMC: 3910500. DOI: 10.1016/j.cell.2013.09.034. View

4.
Neftel C, Laffy J, Filbin M, Hara T, Shore M, Rahme G . An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. 2019; 178(4):835-849.e21. PMC: 6703186. DOI: 10.1016/j.cell.2019.06.024. View

5.
Furnari F, Cloughesy T, Cavenee W, Mischel P . Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma. Nat Rev Cancer. 2015; 15(5):302-10. PMC: 4875778. DOI: 10.1038/nrc3918. View